Migraine prevention: what patients want from medication and their physicians (a headache specialty clinic perspective)
- PMID: 16643577
- DOI: 10.1111/j.1526-4610.2006.00429.x
Migraine prevention: what patients want from medication and their physicians (a headache specialty clinic perspective)
Abstract
Objective: To document the results of a migraine patients survey, from a headache specialty clinic, in which patients were asked to rank, in order of importance, certain characteristics of migraine preventive treatment.
Methods: A 10-question survey was completed by 150 patients (114 females and 36 males) with a history of migraine who presented to the Michigan Head Pain & Neurological Institute. The patients were asked to rank, in order of importance, characteristics of migraine preventive treatment. Each characteristic was rated individually on a 1 to 10 scale (1 being of little importance and 10 being extremely important). The mean rating of each characteristic was then calculated and the results analyzed.
Results/discussion: From this migraine preventive treatment survey, the most important thing to migraineurs, from a headache specialty clinic population, is that the prescribing physician involves them in the decision making of choosing a preventive agent. The physician taking time to explain the possible medication side effects is the second most highly ranked characteristic. Migraine preventives with published efficacy in the medical literature are also deemed very important. Migraineurs do not mind using more than 1 preventive agent at one time if greater efficacy can be achieved. Agents that may affect weight and/or cause sedation may be important factors as to why patients (especially females) may not want to take a preventive medication. Natural therapies and once-daily dosing are ranked lower overall but still are important characteristics of preventive treatment. Some gender differences are noted in the ranking of migraine preventive characteristics.
Comment in
-
Migraine prevention.Headache. 2006 Oct;46(9):1462-3. doi: 10.1111/j.1526-4610.2006.00591_2.x. Headache. 2006. PMID: 17040347 No abstract available.
Similar articles
-
Patients' preference for migraine preventive therapy.Headache. 2007 Apr;47(4):540-5. doi: 10.1111/j.1526-4610.2007.00757.x. Headache. 2007. PMID: 17445103
-
Acute migraine treatment: patterns of use and satisfaction in a clinical population.Headache. 2006 May;46(5):773-80. doi: 10.1111/j.1526-4610.2006.00437.x. Headache. 2006. PMID: 16643580
-
Adherence to acute migraine medication: what does it mean, why does it matter?Headache. 2010 Jan;50(1):117-29. doi: 10.1111/j.1526-4610.2009.01535.x. Epub 2009 Oct 8. Headache. 2010. PMID: 19817884 Review.
-
Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.Headache. 2007 Mar;47(3):355-63. doi: 10.1111/j.1526-4610.2006.00631.x. Headache. 2007. PMID: 17371352
-
Applying the benefits of the AwM study in the clinic.Cephalalgia. 2008 Sep;28 Suppl 2:42-9. doi: 10.1111/j.1468-2982.2008.01690.x. Cephalalgia. 2008. PMID: 18715332 Review.
Cited by
-
Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis.J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):939-944. doi: 10.1136/jnnp-2018-320242. Epub 2019 Apr 19. J Neurol Neurosurg Psychiatry. 2019. PMID: 31004075 Free PMC article. Clinical Trial.
-
Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapy.Ther Clin Risk Manag. 2019 Apr 11;15:557-569. doi: 10.2147/TCRM.S159690. eCollection 2019. Ther Clin Risk Manag. 2019. PMID: 31043785 Free PMC article. Review.
-
Patient Preferences and Values in Decision Making for Migraines: A Systematic Literature Review.Pain Res Manag. 2021 Sep 16;2021:9919773. doi: 10.1155/2021/9919773. eCollection 2021. Pain Res Manag. 2021. PMID: 34567299 Free PMC article.
-
Practical strategies for treating chronic migraine with medication overuse: case examples and role play demonstrations.Neurol Sci. 2009 May;30 Suppl 1:S95-9. doi: 10.1007/s10072-009-0080-4. Neurol Sci. 2009. PMID: 19415435
-
A descriptive review on methods to prioritize outcomes in a health care context.Health Expect. 2015 Dec;18(6):1873-93. doi: 10.1111/hex.12256. Epub 2014 Aug 25. Health Expect. 2015. PMID: 25156207 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical